SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001520138-17-000167
Filing Date
2017-05-09
Accepted
2017-05-08 21:05:25
Documents
42
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR PERIOD ENDED MARCH 31, 2017 bivi-20170331_10q.htm 10-Q 285669
2 EXHIBIT 31.1 bivi-20170331_10qex31z1.htm EX-31.1 12107
3 EXHIBIT 32.1 bivi-20170331_10qex32z1.htm EX-32.1 5797
  Complete submission text file 0001520138-17-000167.txt   1656671

Data Files

Seq Description Document Type Size
4 XBRL LABEL FILE bivi-20170331_lab.xml EX-101.LAB 147431
5 XBRL PRESENTATION FILE bivi-20170331_pre.xml EX-101.PRE 107776
6 XBRL SCHEMA FILE bivi-20170331.xsd EX-101.SCH 18466
7 XBRL INSTANCE FILE bivi-20170331.xml EX-101.INS 278022
8 XBRL CALCULATION FILE bivi-20170331_cal.xml EX-101.CAL 18236
9 XBRL DEFINITION FILE bivi-20170331_def.xml EX-101.DEF 32008
Mailing Address 100 CUMMINGS CENTER, SUITE 247-C BEVERLY MA 01915
Business Address 100 CUMMINGS CENTER, SUITE 247-C BEVERLY MA 01915 312-283-5793
BIOVIE INC. (Filer) CIK: 0001580149 (see all company filings)

IRS No.: 462510769 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-55292 | Film No.: 17824184
SIC: 2834 Pharmaceutical Preparations